Does Multiple PVC Morphologies Change the Need for Ablation?
Yes, having three PVC morphologies significantly affects ablation considerations—it makes the procedure more technically challenging and reduces success rates, but does NOT change the fundamental indications for ablation based on symptoms, PVC burden, or ventricular dysfunction.
Primary Indications Remain Unchanged
The 2017 AHA/ACC/HRS guidelines clearly state that catheter ablation is indicated (Class I) for patients requiring arrhythmia suppression due to symptoms or declining ventricular function when PVCs are generally >15% of beats and "predominately of 1 morphology" 1. This language is critical—the guidelines specifically note that single morphology PVCs are the ideal substrate for ablation.
Impact of Multiple Morphologies on Ablation Success
Multiple morphologies create several challenges:
Lower acute success rates: Research demonstrates that pleomorphic (multiple morphology) PVCs have significantly lower success rates compared to monomorphic PVCs (71% vs 90%, p=0.017) 2
Multiple foci requiring ablation: Three morphologies typically indicate three separate origins that each need to be mapped and ablated 3
Higher epicardial origin likelihood: Pleomorphic PVCs more frequently originate from epicardial sites (29% vs 9%), which are technically more challenging to ablate 2
Clinical Decision Algorithm
When to Proceed with Ablation Despite Multiple Morphologies:
High total PVC burden (>15-20%) with symptoms or LV dysfunction—the primary indication remains valid 1
One clearly predominant morphology accounting for the majority of burden—successful elimination of the predominant PVC often provides clinical benefit even if minor morphologies persist 2
Patient preference over long-term antiarrhythmic therapy and understanding of lower success rates
Experienced operator availability—this becomes even more critical with pleomorphic PVCs 3
Key Threshold for Non-Predominant PVCs:
Research identifies that ≥156 non-predominant PVCs over 24 hours best differentiates successful from unsuccessful ablation procedures (sensitivity 56%, specificity 74%) 2. If the secondary morphologies exceed this threshold, expect greater procedural complexity.
Important Caveats
Common pitfall: Assuming all three morphologies must be eliminated for clinical success. In reality, 80% of recurrences after ablation involve the originally targeted predominant morphology, not emergence of the minor ones 2. Focus efforts on the dominant morphology first.
Technical consideration: Modern automated pace-mapping software has improved outcomes for multifocal PVCs, with successful ablation achievable even when activation mapping cannot be performed due to insufficient ectopic beats during the procedure 3.
Age is not a barrier: In your 73-year-old patient, age alone should not preclude ablation—outcomes are similar in patients ≥65 years versus younger patients 4, 5.
Practical Approach
For this patient with three morphologies:
- Quantify the burden of each morphology on extended Holter monitoring
- If one morphology accounts for >70-80% of total burden and meets the >15% threshold, ablation remains reasonable
- Set realistic expectations: acute success may be 70-85% rather than 90%
- Consider pharmacologic therapy (beta-blockers, amiodarone) as first-line if morphologies are equally distributed 1
- If LV dysfunction is present (PVC-induced cardiomyopathy), ablation becomes more compelling as LVEF typically improves from 38% to 50% post-ablation 6
The presence of multiple morphologies modifies the technical approach and expected success rate but does not fundamentally change whether ablation should be offered—that decision still hinges on PVC burden, symptoms, and ventricular function.